Fertility sparing in cancer patients

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistic, 2009. Cancer J Clin. 2009;59:225–49.
   PubMed Web of Science ®Google Scholar
• Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5–26.
   PubMed Web of Science ®Google Scholar
• Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol. 1999;33:29–33.
   PubMedGoogle Scholar
• The Ethics Committee of the American Society of Reproduction Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83;1622–8.
   PubMed Web of Science ®Google Scholar
• Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies.Gynecol Oncol. 2011;120:326–33.
   Google Scholar
• Schorge JO, Lee KR, Sheets EE. Prospective management of stage IA cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report. Gynecol Oncol. 2000;78:217–20.
   PubMed Web of Science ®Google Scholar
• Sonoda Y, Abu-Rustum NR, Gemignani ML, Chi DS, Brown CL, Poynor EA, A fertility sparing alternative to radical hysterectomy: how many patients may be eligible? Gynecol Oncol. 2004;95:534–8.
   PubMed Web of Science ®Google Scholar
• Plante M, Renaud MC, Hoskins IA, Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol. 2005;98:3–10.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology and End Results. http:// seer.cancer.gov. (Accessed January 16, 2010).
   Google Scholar
• Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25:2798–803.
   PubMed Web of Science ®Google Scholar
• Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95:133–8.
   PubMed Web of Science ®Google Scholar
• Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ. Intrauterine progesterone treatment of early endometrial cancer. Am J O bstet Gynecol. 2002;186:651–7.
   PubMed Web of Science ®Google Scholar
• Schilder JM, Thompson AM, DePriest PD, Ueland FR, Cibull ML, Kryscio RJ, Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol. 2002;87:1–7.
   PubMed Web of Science ®Google Scholar
• Zanetta G, Chiari S, Rota S, Bratina G, Maneo A, Torri V, Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynecol. 1997;104:1030–5.
   PubMedGoogle Scholar
• Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safery and reproductive outcomes. Gynecol Oncol. 2008;110:345–53.
   PubMed Web of Science ®Google Scholar
• Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001;19:2658–64.
   PubMed Web of Science ®Google Scholar
• Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 2001;75:92–6.
   PubMed Web of Science ®Google Scholar
• Tangir J, Zelterman D, Ma W, Schwartz PE. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol. 2003;101:251–7.
   PubMed Web of Science ®Google Scholar
• Zanetta G, Bonazzi C, Cantù M, Binidagger S, Locatelli A, Bratina G, Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001;19:1015–20.
   PubMed Web of Science ®Google Scholar
• Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endoctinol Metab. 1997;82:3748–51.
   PubMed Web of Science ®Google Scholar
• Oktay K, Newton H, Mullan J, Gosden RG. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod. 1998;13:1133–8.
   PubMed Web of Science ®Google Scholar
• Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007;110:2222–9.
   PubMed Web of Science ®Google Scholar
• Wallace B, Kelsey T. Human ovarian reserve from conception to the menopause. PLoS One. 2010;27:e8772.
   Google Scholar
• Utsunomiya T, Tanaka T, Utsunomiya H, Umesaki N A novel molecular mechanism for anticancer drug-induced ovarian failure: irinoteca HCI, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis. Int J Oncol. 2008;32:991–1000.
   PubMed Web of Science ®Google Scholar
• Oktem O, Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007;67:10159–62.
   PubMed Web of Science ®Google Scholar
• Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53:727–39.
   PubMed Web of Science ®Google Scholar
• Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol and Cell Endocr. 2000;169:123–31.
   PubMed Web of Science ®Google Scholar
• Nicosia S, Matus-Ridley M, Meadows AT. Gonadal effect of cancer therapy in girls. Cancer 1985;55:2364–72.
   PubMed Web of Science ®Google Scholar
• Plowchalk DR, Mattison DR. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide. Toxicol Appl Pharmacol. 1991;107;472–81.
   PubMed Web of Science ®Google Scholar
• Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R. The rates of chemotherapy-induced amenprrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol. 2007;30:126–32.
   PubMed Web of Science ®Google Scholar
• Oktay K, Sönmezer M. Chemotherapy and amenorrhea: risks and treatment options. Curr Opin Obstet Gynecol. 2008;20:408–15.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K. American society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.
   PubMed Web of Science ®Google Scholar
• Bines J, Oleske DM, Cobleigh MA. Ovarian function in premenopausal women treated wth adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14;1718–29.
   PubMed Web of Science ®Google Scholar
• Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol. 2006;24:1045–51.
   PubMed Web of Science ®Google Scholar
• Knopman JM, Papadopoulos EB, Grifo JA, Fino ME, Noyes N. Surviving childhood and reproductive age malignancy: effects of treatment on fertility, gametes and future parenthood. Lancet Oncol. 2010;11:490–8.
   PubMed Web of Science ®Google Scholar
• Licciardi, F, Liu H, Rosenwks. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995;64:991–4.
   PubMed Web of Science ®Google Scholar
• Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum Mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:468–71.
   PubMed Web of Science ®Google Scholar
• Lie Fong S, Lugtenburg PJ, Schipper I, Themmen AP, De Jong FH, Sonneveld P, Antimullerian hormone as a marker of ovarian function in women after chemotherapy and radiotheraphy for hematological malignancies. Human Reprod. 2008;23:674–8.
   PubMed Web of Science ®Google Scholar
• Seifer DB, Lambert-Messerlian G, Hogan JW, Gardiner AC, Blazar AS, Berk CA. Day 3 serum inhibin-B predictive of assisted reproductive technologies outcome. Fertil Steril. 1997;67:110–14.
   PubMed Web of Science ®Google Scholar
• Ng EH, Yeung WS, Fong DY, Ho PC. Effect of age on hormonal and ultrasound markers of ovarian reserve in Chinese women with proven fertility. Hum Reprod. 2003;18:2169–74.
   PubMed Web of Science ®Google Scholar
• Gosden RG, Wade JC, Fraser HM, Sandow J, Faddy MJ. Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary. Hum Reprod. 1997;12:2483–8.
   PubMed Web of Science ®Google Scholar
• Dobrzynska MM. Assessment of DNA damage in multiple organs from mice exposed to X-rays or acrylamide or a combination of bothh using the comet assay. In Vivo. 2007;21:657–62.
   PubMed Web of Science ®Google Scholar
• Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989;43:399–402.
   PubMed Web of Science ®Google Scholar
• Critchley HO, Bath LE, Wallace WH. Radiation damage to the uterus-review of the effects of treatment of childhood cancer. Hum Steril (Camb). 2002;5:61–6.
   PubMedGoogle Scholar
• Wallace WH, Thomson AB, Kelsey RW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117–21.
   PubMed Web of Science ®Google Scholar
• Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathies. N Eng J Med. 2001;344:1567–71.
   PubMed Web of Science ®Google Scholar
• Boice JD Jr, Tawn EJ, Winther JF, Donaldson SS, Green DM, Mertens AC, Genetic effects of radiotherapy for childhood cancer. Health Phys. 2003;85:65–80.
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, von Wolff M. GnRH analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod. 2008;14:543–52.
   Web of Science ®Google Scholar
• Reinsch RC, Murphy AA, Morales AJ, Yen SS. The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: A prospective, randomized study. Am J O bstet Gynecol. 1994;170:1623–7.
   PubMed Web of Science ®Google Scholar
• Ng EH, Tang OS, Chan CC, Ho PC. Ovarial stromal blood flow in the prediction of ovarian response during in vitro fertilization treatment. Hum Reprod. 2005;20:3147–51.
   PubMed Web of Science ®Google Scholar
• Jarvela IY, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G. Effect of pituitary down-regulation on the ovary before in vitro fertilization as measured using three-dimensional power Doppler ultrasound. Fertil Steril. 2003;79:1129–35.
   PubMed Web of Science ®Google Scholar
• Imai A, Sugiyama M, Furui T, Tamaya T, Ohno T. Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulose cell damage. Gynecol Obstet Invest. 2007;63:102–6.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Women's Health. 2009;18:311–18.
   PubMed Web of Science ®Google Scholar
• Oktay K, Sonmezer M, Oktem O. Ovarian cryopreservation versus ovarian suppression by GnRH analogues: Primum non nocere: Reply. Hum Reprod. 2004;19:1681–3.
   PubMed Web of Science ®Google Scholar
• Morita Y, Perez GL, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1 phosphate therapy. Nat Med. 2000;6:1109–14.
   PubMed Web of Science ®Google Scholar
• Paris F, Perez GL, Fuks Z, Haimovitz-Friedman A, Nguyen H, Bose M, Sphingosine 1-phosphaste preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med. 2002;8:901–2.
   PubMed Web of Science ®Google Scholar
• Gonfloni S, Di Tella L, Caldarola S, Cannata SM, Klinger FG, Di Bartolomeo C, Inhibition of the cAbl-Tap63 pathway protects mouse oocytes from chemotherapy-induced deaty. Nat Med. 2009;15:1179–85.
   PubMed Web of Science ®Google Scholar
• Cowles RA, Gewanter RM, Kandel JJ. Ovarian repositioning in pediatric cancer patients: flexible techniques accommodate pelvic radiation fields. Pediatr Blood Cancer. 2007;49:339–41.
   PubMed Web of Science ®Google Scholar
• Falcone T, Attaran M, Bedaiwy MA Goldberg JM. Ovarian function preservation in the cancer patient. Fertil Steril. 2004;81:243–57.
   PubMed Web of Science ®Google Scholar
• Zeilmaker G, Alberda A, Van Gent I Rijkmans CM, Drogendijk AC. Two pregnancies following transfer of intact frozen thawed embryos. Fertil Steril. 1984;42:293–6.
   PubMed Web of Science ®Google Scholar
• Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol. 2010; doi:10.1016/j.ygyno.2010.09.012.
   Google Scholar
• Noyes N, Porcu E, Borini A. With more than 900 babies born, live birth outcomes following oocyte cryopreservation do not appear different from those occurring after conventional IVF. Reprod Biomed Online. 2009;18:769–76.
   PubMed Web of Science ®Google Scholar
• Ata B, Chian RC, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Re Clin Obstet Gynecol. 2010;24:101–12.
   PubMed Web of Science ®Google Scholar
• Bedoschi GM, Albuquerque FO, Ferriani RA, Navarro PA. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature. J Assist Reprod Genet. 2010;27:491–4.
   PubMed Web of Science ®Google Scholar
• Von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009;92:1360–5.
   PubMed Web of Science ®Google Scholar
• Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003;69:1023–31.
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertalla N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347–53.
   PubMed Web of Science ®Google Scholar
• Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with lertozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26:2630–5.
   PubMed Web of Science ®Google Scholar
• Oktay K, Demirtas E, Son WY, Lostritto K, Chian RC, Tan SL. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation. Fertil Steril. 2008;89:19–22.
   Web of Science ®Google Scholar
• Li Y, Feng HL, Cao YJ, Zheng GJ, Yang Y, Mullen S, Confocal microscopic analysis of the spindle and chromosome configurations of human oocytes matured in vitro. Fertil Steril. 2006;85:827–32.
   PubMed Web of Science ®Google Scholar
• Huang JY, Chen HY, Park JY, Tan SL, Chian RC. Comparison of spindle and chromosome configuration in in vitro and in vivo matured mouse oocytes after vitrification. Fertil Steril. 2007;76:334–9.
   Google Scholar
• Manipalvirath S, Decherney A. Clinical application of human oocyte cryopreservation. Rev Recent Clin Trials. 2008;3:104–10.
   PubMedGoogle Scholar
• Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1:884–6.
   PubMed Web of Science ®Google Scholar
• Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70–80.
   PubMed Web of Science ®Google Scholar
• Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2010;93:391–6.
   PubMed Web of Science ®Google Scholar
• Bos-Mikich A, Ferreira M, Höher M, Frantz G, Oliveira N, Dutra CG, Fertilization outcome, embryo development and birth after unstimulated IVF. J Assist Reprod Genet. 2010; DOI 10.1007/s 10815-010-9490-8.
   Google Scholar
• Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertil Steril. 2010;93:762–8.
   PubMed Web of Science ®Google Scholar
• Keros V, Xella S, Hultenby K, Pettersson K, Sheikhi M, Volpe A, Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod. 2009;24:1670–83.
   PubMed Web of Science ®Google Scholar
• Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update 2009;15:649–65.
   PubMed Web of Science ®Google Scholar
• Martinez-Madrid B, Camboni A, Dolmans MM, Nottola S, Van Langendonckt A, Donnez J. Apoptosis and ultra-structural assessment after cryopreservation of whole human ovaries with their vascular pedicle. Fertil Steril. 2007;87:1153–65.
   PubMed Web of Science ®Google Scholar
• Sönmezer M, Oktay K. Assisted reproduction and fertility preservation techniques in cancer patients. Curr Opin Endocrinol Diabetes Obes. 2008;15:514–22.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Cryopreservation and transplantation of ovarian tissue. Clin Obstet Gynecol. 2010;53:787–96.
   PubMed Web of Science ®Google Scholar
• Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23:1007–13.
   PubMed Web of Science ®Google Scholar
• Georgeskou E, Goldberg J, Plessis S, Agarwal A. Present and future fertility preservation strategies for female cancer patients. Obstet Gynecol Surv. 2008;63:725–32.
   PubMed Web of Science ®Google Scholar
• Sönmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251–66.
   PubMed Web of Science ®Google Scholar
• Lucifero D, Mertineit C, Clarke HJ, Bestor TH, Trasler JM. Methylation dynamics of imprinted genes in mouse germ cells. Genomics. 2002;79:530–8.
   PubMed Web of Science ®Google Scholar
• Holzer H, Scharf E, Chian RC, Demirtas E, Buckett W, Tan SL. In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation. Fertil Steril. 2007;88:62–7.
   PubMed Web of Science ®Google Scholar
• Nagy ZP, Chang CC. Current advances in artificial gametes. Reprod Biomed Online. 2005;11:332–9.
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Neri QV, Palermo GD. Construction and fertilization of reconstituted human oocytes. Reprod Biomed Online. 2005;11:309–18.
   PubMed Web of Science ®Google Scholar
• Maltaris T, Seufert R, Fischl F, Schaffrath M, Pollow K, Koelbl H, The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Biol. 2007;130:148–55.
   PubMed Web of Science ®Google Scholar
• Nagy ZP, Chang CC. Artificial gametes. Theriogenology. 2007;67:99–104.
   PubMed Web of Science ®Google Scholar
• FertiPROTECT (2009) Network for fertility preservation before chemo-and radiotherapy. Available at: http://www.fertiprotect.de/index.php?lang=uk. Accessed 13 November 2009.
   Google Scholar